ArticleMaterials (Basel, Switzerland)2024
Possibilities of Managing Waste Iron Sorbent FFH after CO
Article in Materials (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
With a growing need to reduce greenhouse gas emissions, innovative carbon dioxide sorbents are being sought. One of the sorbents being tested is nanoparticle ferric hydrosol (FFH). In parallel with sorbent testing, it is also necessary to test the used sorbent after carbon dioxide capture (FFHCO2) and to develop an optimal method for its processing and management. The research described in this article evaluated the potential use of FFHCO2 in dewatering, coagulation and bioleaching processes. The research results indicate that the basic strategy for dealing with waste FFHCO2 sorbent should be to minimize the amount of waste by volume reduction-dewatering. Recycling of FFHCO2 as an iron waste coagulant or its processing products by bioleaching had no technological justification. It is only proposed to recover the material-iron compounds-if it is environmentally and economically justified.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.